SQLE inhibitors, such as terbinafine, can reduce the immunosuppressive activity of MDSC, restore CD8+ T cell function, and improve the efficacy of PD-1 inhibitors in HCC[66]. Here, CD8A is linked to hepatocellular carcinoma.